We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+7.58%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.41B
AUM Growth
-$3.75B
Cap. Flow
-$4.09B
Cap. Flow %
-169.35%
Top 10 Hldgs %
31.78%
Holding
6,989
New
537
Increased
1,703
Reduced
3,620
Closed
686

Sector Composition

Rank Sector Weight
1 Technology 21.71%
2 Healthcare 7.7%
3 Consumer Discretionary 6.83%
4 Financials 6.52%
5 Industrials 4.92%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNPO
1576
DELISTED
Snap One Holdings Corp. Common Stock
SNPO
$139K 0.01%
18,639
+6,362
+52% +$58.7K
CRSP icon
1577
CRISPR Therapeutics
CRSP
$5.23B
$138K 0.01%
3,396
-23,594
-87% -$1.25M
HZO icon
1578
MarineMax
HZO
$1.16B
$138K 0.01%
4,417
-3,858
-47% -$121K
SPOT icon
1579
Spotify
SPOT
$103B
$138K 0.01%
1,742
-7,896
-82% -$637K
SRCE icon
1580
1st Source
SRCE
$2.12B
$138K 0.01%
2,602
+225
+9% +$12.3K
BANF icon
1581
BancFirst
BANF
$3.82B
$137K 0.01%
1,557
-2,639
-63% -$249K
ATRC icon
1582
AtriCure
ATRC
$2.18B
$136K 0.01%
3,058
-1,760
-37% -$73.5K
AUPH icon
1583
Aurinia Pharmaceuticals
AUPH
$2.04B
$136K 0.01%
31,512
+24,609
+356% +$143K
BKU icon
1584
Bankunited
BKU
$3.35B
$136K 0.01%
4,012
-13,305
-77% -$470K
EFG icon
1585
iShares MSCI EAFE Growth ETF
EFG
$17.3B
$136K 0.01%
1,621
+1,614
+23,057% +$130K
EHC icon
1586
Encompass Health
EHC
$12.4B
$136K 0.01%
2,267
-7,336
-76% -$399K
PJP icon
1587
Invesco Pharmaceuticals ETF
PJP
$498M
$136K 0.01%
1,737
-5,663
-77% -$435K
WWW icon
1588
Wolverine World Wide
WWW
$1.49B
$136K 0.01%
12,420
+3,139
+34% +$41.7K
IVAC
1589
DELISTED
Intevac Inc
IVAC
$136K 0.01%
21,067
-227
-1% -$1.22K
SRCL
1590
DELISTED
Stericycle Inc
SRCL
$136K 0.01%
2,720
-2,019
-43% -$96.1K
ALK icon
1591
Alaska Air
ALK
$5.4B
$135K 0.01%
3,135
-3,747
-54% -$165K
INSW icon
1592
International Seaways
INSW
$4.41B
$135K 0.01%
3,645
+581
+19% +$23.5K
KYMR icon
1593
Kymera Therapeutics
KYMR
$9.11B
$135K 0.01%
5,399
-13,223
-71% -$353K
NVS icon
1594
Novartis
NVS
$294B
$135K 0.01%
1,494
+343
+30% +$28.9K
OZK icon
1595
Bank OZK
OZK
$5.66B
$135K 0.01%
3,382
-3,093
-48% -$133K
SPUU icon
1596
Direxion Daily S&P 500 Bull 2X ETF
SPUU
$280M
$135K 0.01%
1,902
-3,793
-67% -$275K
WEX icon
1597
WEX
WEX
$6.44B
$135K 0.01%
826
-10,536
-93% -$1.64M
CXT icon
1598
Crane NXT
CXT
$2.95B
$134K 0.01%
3,846
-910
-19% -$31.7K
LEG icon
1599
Leggett & Platt
LEG
$1.3B
$134K 0.01%
4,171
-5,337
-56% -$180K
PHG icon
1600
Philips
PHG
$26.4B
$134K 0.01%
10,476
+309
+3% +$3.73K

Similar funds

Tower Research Capital (TRC)'s Q4 2022 Portfolio in Review

As of Q4 2022, Tower Research Capital (TRC) held 6,989 positions worth $2.41B, down 61% from $6.16B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Tower Research Capital (TRC) withdrew a net $4.09B in Q4 2022, closing 686 positions and reducing 3,620 holdings. Its most notable exit was Vanguard Russell 2000 Value ETF, an estimated $4.46M position sold in full.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Semiconductor ETF worth $9.33M.

  • Tower Research Capital (TRC)'s largest Q4 2022 buy was iShares Semiconductor ETF: 80,454 shares worth $9.33M.
  • Tower Research Capital (TRC) added most to iShares Russell 2000 ETF in Q4 2022, an estimated $145M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2022 reduction was Apple, cutting an estimated $322M.
  • Tower Research Capital (TRC) fully exited Vanguard Russell 2000 Value ETF in Q4 2022, selling an estimated $4.46M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 32% of its $2.41B portfolio in Q4 2022.
  • Tower Research Capital (TRC) opened 537 new positions and closed 686 in Q4 2022.
  • Tower Research Capital (TRC)'s portfolio value fell 61% quarter-over-quarter to $2.41B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.